Literature DB >> 22729951

Testosterone and heart failure.

Maurizio Volterrani1, Giuseppe Rosano, Ferdinando Iellamo.   

Abstract

Testosterone deficiency is a generalized phenomenon seen in the course of chronic heart failure (CHF). Reduction in circulating testosterone level is a predictor of deterioration of functional capacity over time, underscoring the role of testosterone deficiency in CHF. Anabolic hormones are determinants of exercise capacity and circulating levels of anabolic hormones strongly determine muscle mass and strength. Testosterone deficiency is involved in the pathophysiology of CHF, contributing to some features of this syndrome, such as the reduced muscle mass, abnormal energy handling, fatigue, dyspnea and, finally, cachexia. This review summarizes current knowledge on the role of testosterone deficiency in the pathophysiology of CHF, gaining insights from the potential implications of testosterone as supplementation therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729951     DOI: 10.1007/s12020-012-9725-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  57 in total

1.  Acute haemodynamic effects of testosterone in men with chronic heart failure.

Authors:  Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

2.  Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.

Authors:  S D Anker; A L Clark; M Kemp; C Salsbury; M M Teixeira; P G Hellewell; A J Coats
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Development of a ventilatory classification system in patients with heart failure.

Authors:  Ross Arena; Jonathan Myers; Joshua Abella; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Marco Guazzi
Journal:  Circulation       Date:  2007-04-23       Impact factor: 29.690

4.  Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure.

Authors:  Massimo F Piepoli; Agnieszka Kaczmarek; Darrel P Francis; L Ceri Davies; Mathias Rauchhaus; Ewa A Jankowska; Stefan D Anker; Alessandro Capucci; Waldemar Banasiak; Piotr Ponikowski
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

5.  Cardiomyoplasty - improvement of muscle fibre type transformation by an anabolic steroid (metenolone).

Authors:  M Czesla; G Mehlhorn; D Fritzsche; G Asmussen
Journal:  J Mol Cell Cardiol       Date:  1997-11       Impact factor: 5.000

6.  Insulin resistance and risk of congestive heart failure.

Authors:  Erik Ingelsson; Johan Sundström; Johan Arnlöv; Björn Zethelius; Lars Lind
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

7.  Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.

Authors:  Arny A Ferrando; Melinda Sheffield-Moore; Catherine W Yeckel; Charles Gilkison; Jie Jiang; Alison Achacosa; Steven A Lieberman; Kevin Tipton; Robert R Wolfe; Randall J Urban
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

8.  Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study.

Authors:  R B Simerly; C Chang; M Muramatsu; L W Swanson
Journal:  J Comp Neurol       Date:  1990-04-01       Impact factor: 3.215

9.  Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.

Authors:  K K Miller; B M K Biller; C Beauregard; J G Lipman; J Jones; D Schoenfeld; J C Sherman; B Swearingen; J Loeffler; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2006-02-14       Impact factor: 5.958

10.  Orchiectomy or androgen receptor blockade attenuates baroreflex-mediated bradycardia in conscious rats.

Authors:  Gregg R Ward; Abdel A Abdel-Rahman
Journal:  BMC Pharmacol       Date:  2006-01-23
View more
  10 in total

1.  Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.

Authors:  D Francomano; R Bruzziches; G Barbaro; A Lenzi; A Aversa
Journal:  J Endocrinol Invest       Date:  2014-03-18       Impact factor: 4.256

Review 2.  Testosterone in men with hypogonadism and high cardiovascular risk, Pros.

Authors:  Giuseppe M C Rosano; Cristiana Vitale; Massimo Fini
Journal:  Endocrine       Date:  2015-03-07       Impact factor: 3.633

Review 3.  Testosterone deficiency, insulin-resistant obesity and cognitive function.

Authors:  Hiranya Pintana; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  Metab Brain Dis       Date:  2015-02-24       Impact factor: 3.584

4.  Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial.

Authors:  Armin Zittermann; Jana B Ernst; Sylvana Prokop; Uwe Fuchs; Jens Dreier; Joachim Kuhn; Cornelius Knabbe; Heiner K Berthold; Ioanna Gouni-Berthold; Jan F Gummert; Jochen Börgermann; Stefan Pilz
Journal:  Eur J Nutr       Date:  2018-03-15       Impact factor: 5.614

5.  Central and peripheral testosterone effects in men with heart failure: An approach for cardiovascular research.

Authors:  Željko Bušić; Viktor Čulić
Journal:  World J Cardiol       Date:  2015-09-26

6.  Natural course of hypogonadism diagnosed during hospitalization in aged male patients.

Authors:  P Iglesias; F Prado; A Muñoz; M T Guerrero; M C Macías; E Ridruejo; P Tajada; C García-Arévalo; J J Díez
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

Review 7.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633

8.  A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure.

Authors:  Ying Han; Weiju Sun; Guizhi Sun; Xiaolu Hou; Zhaowei Gong; Jing Xu; Xiuping Bai; Lu Fu
Journal:  Oncotarget       Date:  2017-08-02

9.  Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity.

Authors:  Antonio Mancini; Angela Maria Rita Fuvuzzi; Carmine Bruno; Maria Anna Nicolazzi; Edoardo Vergani; Nunzia Ciferri; Andrea Silvestrini; Elisabetta Meucci; Nicola Nicolotti; Roberta D'Assante; Antonio Cittadini
Journal:  Int J Endocrinol       Date:  2020-01-03       Impact factor: 3.257

Review 10.  Role of Vitamin D Supplementation in Heart Failure Patients With Vitamin D Deficiency and Its Effects on Clinical Outcomes: A Literature Review.

Authors:  Vishal Busa; Ahmed Dardeir; Suganya Marudhai; Mauli Patel; Sharathshiva Valaiyaduppu Subas; Mohammad R Ghani; Ivan Cancarevic
Journal:  Cureus       Date:  2020-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.